Prudential Financial
DTIL icon

Prudential Financial’s Precision BioSciences DTIL Stock Holding History

Prudential Financial’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,752
Closed -$30.1K – 2690
2023
Q4 		$30.1K Buy
2,752
+307
+13% +$3.31K ﹤0.01% 2595
2023
Q3 		$25K Buy
+2,445
New +$37.6K ﹤0.01% 2562
2022
Q2 		– Sell
-4,922
Closed -$455K – 2688
2022
Q1 		$455K Buy
+4,922
New +$669K ﹤0.01% 2241
2021
Q4 		– Sell
-775
Closed -$268K – 2650
2021
Q3 		$268K Buy
+775
New +$263K ﹤0.01% 2367

Other funds holding DTIL

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Prudential Financial's DTIL Position: Q1 2024 in Review

Prudential Financial sold out of Precision BioSciences (DTIL) in Q1 2024, closing a stake of 2,752 shares — an estimated $30.1K sold.

Prudential Financial first reported a position in DTIL in Q3 2021 and held it in 4 quarters. The position peaked at $455K in Q1 2022. 43 funds tracked by Wall St. Rank hold DTIL as of Q1 2024.

  • Prudential Financial reported no remaining Precision BioSciences position as of Q1 2024 after selling out during the quarter.
  • Prudential Financial sold 2,752 Precision BioSciences shares in Q1 2024, an estimated $30.1K.
  • Prudential Financial first reported a position in Precision BioSciences in Q3 2021 and held it in 4 quarters.
  • Prudential Financial's Precision BioSciences position peaked at $455K in Q1 2022.
  • 43 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2024.

Based on Prudential Financial's 13F filing for Q1 2024, filed 14 May 2024.